0001013762-23-001574.txt : 20231004
0001013762-23-001574.hdr.sgml : 20231004
20231004160529
ACCESSION NUMBER: 0001013762-23-001574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231002
FILED AS OF DATE: 20231004
DATE AS OF CHANGE: 20231004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DiPerna Paul
CENTRAL INDEX KEY: 0001506126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41277
FILM NUMBER: 231307927
MAIL ADDRESS:
STREET 1: 16772 W BERNARDO DRIVE
CITY: RANCHO BERNARDO
STATE: CA
ZIP: 92127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Modular Medical, Inc.
CENTRAL INDEX KEY: 0001074871
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 870620495
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 16772 WEST BERNARDO DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
BUSINESS PHONE: 858-800-3500
MAIL ADDRESS:
STREET 1: 16772 WEST BERNARDO DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
FORMER COMPANY:
FORMER CONFORMED NAME: BEAR LAKE RECREATION INC
DATE OF NAME CHANGE: 19981208
4
1
ownership.xml
X0508
4
2023-10-02
0
0001074871
Modular Medical, Inc.
MODD
0001506126
DiPerna Paul
C/O MODULAR MEDICAL, INC
10740 THORNMINT ROAD
SAN DIEGO
CA
92127
1
1
1
0
See Remarks
0
Option to purchase common stock
1.11
2023-10-02
4
A
0
90091
1.11
A
2033-10-02
Common Stock
90091
90091
D
Option to purchase common stock
1.11
2023-10-02
4
A
0
45046
1.11
A
2033-10-02
Common Stock
45046
45046
D
This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.
In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) premarket submission on or before August 1, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on August 2, 2024.
Chairman, President, Chief Financial Officer and Treasurer
/s/ James Sullivan, attorney-in-fact for Paul DiPerna
2023-10-04